Baird Financial Group, Inc. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 75 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,256,000
+6.4%
162,275
-23.0%
0.01%0.0%
Q2 2016$1,180,000
-16.0%
210,777
-19.2%
0.01%
-15.4%
Q1 2016$1,404,000
-36.8%
260,948
+2.2%
0.01%
-40.9%
Q4 2015$2,223,000
-1.9%
255,211
-5.6%
0.02%
-8.3%
Q3 2015$2,267,000
-57.9%
270,225
-11.6%
0.02%
-54.7%
Q2 2015$5,388,000305,7910.05%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Paloma Partners Management Co 3,775,000$1,359,0000.05%
Oaktree Fund Advisors, LLC 66,000$23,7600.02%
GoalVest Advisory LLC 32,915$11,8490.01%
Houlihan Financial Resource Group, Ltd. 30,000$110.01%
Granite Bay Wealth Management, LLC 22,520$80.01%
S&T BANK/PA 38,853$140.00%
Lattice Capital Management, LLC 51,800$18,6480.00%
Modus Advisors, LLC 19,706$7,0940.00%
Crescent Grove Advisors, LLC 60,000$21,6000.00%
SlateStone Wealth, LLC 21,433$80.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders